{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:26:58Z","timestamp":1787657218180,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":1484,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1074\/jbc.m116.724070","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T01:53:13Z","timestamp":1466819593000},"page":"17427-17436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I\u03b1 Oxidation"],"prefix":"10.1016","volume":"291","author":[{"given":"Oleksandra","family":"Prysyazhna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Robert","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Scotcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.724070_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin cardiomyopathy","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"10.1074\/jbc.M116.724070_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","article-title":"Mechanisms and management of doxorubicin cardiotoxicity","volume":"36","author":"Shi","year":"2011","journal-title":"Herz"},{"key":"10.1074\/jbc.M116.724070_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1124\/jpet.110.170191","article-title":"Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect","volume":"334","author":"Koka","year":"2010","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M116.724070_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ. Heart Fail"},{"key":"10.1074\/jbc.M116.724070_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol. Rev"},{"key":"10.1074\/jbc.M116.724070_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1126\/science.1144318","article-title":"Cysteine redox sensor in PKGIa enables oxidant-induced activation","volume":"317","author":"Burgoyne","year":"2007","journal-title":"Science"},{"key":"10.1074\/jbc.M116.724070_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nm.2603","article-title":"Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension","volume":"18","author":"Prysyazhna","year":"2012","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M116.724070_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.112.198754","article-title":"cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control","volume":"60","author":"Burgoyne","year":"2012","journal-title":"Hypertension"},{"key":"10.1074\/jbc.M116.724070_bib9","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.freeradbiomed.2012.08.011","article-title":"H2O2 lowers the cytosolic Ca2+ concentration via activation of cGMP-dependent protein kinase I\u03b1","volume":"53","author":"M\u00fcller","year":"2012","journal-title":"Free Radic Biol. Med"},{"key":"10.1074\/jbc.M116.724070_bib10","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","article-title":"Redox cycling of anthracyclines by cardiac mitochondria: I. Anthracycline radical formation by NADH dehydrogenase","volume":"261","author":"Davies","year":"1986","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.724070_bib11","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1172\/JCI80275","article-title":"Prevention of PKG1\u03b1 oxidation augments cardioprotection in the stressed heart","volume":"125","author":"Nakamura","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M116.724070_bib12","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1073\/pnas.1301026110","article-title":"Protein kinase G oxidation is a major cause of injury during sepsis","volume":"110","author":"Rudyk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.724070_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCULATIONAHA.112.101287","article-title":"Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1\u03b1 knock-in mouse","volume":"126","author":"Rudyk","year":"2012","journal-title":"Circulation"},{"key":"10.1074\/jbc.M116.724070_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/HYPERTENSIONAHA.114.04281","article-title":"Protein kinase G I\u03b1 oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide","volume":"64","author":"Stubbert","year":"2014","journal-title":"Hypertension"},{"key":"10.1074\/jbc.M116.724070_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.RES.0000258451.44949.d7","article-title":"Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart","volume":"100","author":"Yan","year":"2007","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M116.724070_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1056\/NEJM198309293091302","article-title":"Evaluation of a new bipyridine inotropic agent\u2013milrinone\u2013in patients with severe congestive heart failure","volume":"309","author":"Baim","year":"1983","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M116.724070_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.724070_bib18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1124\/mol.105.017608","article-title":"Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line","volume":"68","author":"Wunder","year":"2005","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M116.724070_bib19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1074\/jbc.M116.724070_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ijir.2012.35","article-title":"Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice","volume":"25","author":"da Silva","year":"2013","journal-title":"Int. J. Impot. Res"},{"key":"10.1074\/jbc.M116.724070_bib21","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","article-title":"Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity","volume":"111","author":"Fisher","year":"2005","journal-title":"Circulation"},{"key":"10.1074\/jbc.M116.724070_bib22","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1073\/pnas.1006965107","article-title":"Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction","volume":"107","author":"Das","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.724070_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jjcc.2013.03.018","article-title":"Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy","volume":"62","author":"Jin","year":"2013","journal-title":"J. Cardiol"},{"key":"10.1074\/jbc.M116.724070_bib24","doi-asserted-by":"crossref","first-page":"e003731","DOI":"10.1161\/JAHA.112.003731","article-title":"Protein kinase Gi\u03b1 inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo","volume":"1","author":"Blanton","year":"2012","journal-title":"J. Am. Heart Assoc"},{"key":"10.1074\/jbc.M116.724070_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2008.08.069","article-title":"Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload","volume":"53","author":"Nagayama","year":"2009","journal-title":"J. Am. Coll Cardiol"},{"key":"10.1074\/jbc.M116.724070_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M116.724070_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000065431","article-title":"Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells","volume":"11","author":"Fiscus","year":"2002","journal-title":"Neurosignals"},{"key":"10.1074\/jbc.M116.724070_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.RES.84.3.253","article-title":"Nitric oxide as a bifunctional regulator of apoptosis","volume":"84","author":"Kim","year":"1999","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M116.724070_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1540-8191.2001.tb01153.x","article-title":"Nitric oxide and cyclic GMP as pro- and anti-apoptotic agents","volume":"17","author":"Fiscus","year":"2002","journal-title":"J. Card. Surg"},{"key":"10.1074\/jbc.M116.724070_bib30","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1038\/cddis.2013.243","article-title":"RhoA modulates functional and physical interaction between ROCK1 and Erk1\/2 in selenite-induced apoptosis of leukaemia cells","volume":"4","author":"Li","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1074\/jbc.M116.724070_bib31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","article-title":"The Rac and Rho hall of fame: a decade of hypertrophic signaling hits","volume":"98","author":"Brown","year":"2006","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M116.724070_bib32","doi-asserted-by":"crossref","first-page":"ra100","DOI":"10.1126\/scisignal.2005262","article-title":"RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis","volume":"7","author":"Lauriol","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.M116.724070_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1074\/jbc.M508847200","article-title":"The structure of dimeric ROCK I reveals the mechanism for ligand selectivity","volume":"281","author":"Jacobs","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.724070_bib34","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1074\/jbc.M213066200","article-title":"Serine phosphorylation negatively regulates RhoA in vivo","volume":"278","author":"Ellerbroek","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.724070_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/01.RES.0000201960.04223.3c","article-title":"Rho kinases in cardiovascular physiology and pathophysiology","volume":"98","author":"Loirand","year":"2006","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M116.724070_bib36","doi-asserted-by":"crossref","first-page":"41342","DOI":"10.1074\/jbc.M112.421040","article-title":"Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase I\u03b1","volume":"287","author":"Kato","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.724070_bib37","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1073\/pnas.0802128105","article-title":"High blood pressure arising from a defect in vascular function","volume":"105","author":"Michael","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.724070_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nm.2634","article-title":"cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function","volume":"18","author":"Jaumann","year":"2012","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M116.724070_bib39","doi-asserted-by":"crossref","first-page":"21827","DOI":"10.1074\/jbc.M603952200","article-title":"Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation","volume":"281","author":"Brennan","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M116.724070_bib40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jmb.2007.11.053","article-title":"cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain","volume":"375","author":"Alverdi","year":"2008","journal-title":"J. Mol. Biol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820334785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820334785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.724070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T05:44:44Z","timestamp":1641275084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820334785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0021925820334785"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.724070","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G I\u03b1 Oxidation","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.724070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}